4l1d: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Voltage-gated sodium channel beta3 subunit Ig domain== | ==Voltage-gated sodium channel beta3 subunit Ig domain== | ||
<StructureSection load='4l1d' size='340' side='right' caption='[[4l1d]], [[Resolution|resolution]] 2.50Å' scene=''> | <StructureSection load='4l1d' size='340' side='right'caption='[[4l1d]], [[Resolution|resolution]] 2.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4l1d]] is a 3 chain structure with sequence from [ | <table><tr><td colspan='2'>[[4l1d]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L1D OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4L1D FirstGlance]. <br> | ||
</td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4l1d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l1d OCA], [https://pdbe.org/4l1d PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4l1d RCSB], [https://www.ebi.ac.uk/pdbsum/4l1d PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4l1d ProSAT]</span></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Disease == | == Disease == | ||
[ | [https://www.uniprot.org/uniprot/SCN3B_HUMAN SCN3B_HUMAN] Brugada syndrome. The disease is caused by mutations affecting the gene represented in this entry. | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/SCN3B_HUMAN SCN3B_HUMAN] Modulates channel gating kinetics. Causes unique persistent sodium currents. Inactivates the sodium channel opening more slowly than the subunit beta-1. Its association with neurofascin may target the sodium channels to the nodes of Ranvier of developing axons and retain these channels at the nodes in mature myelinated axons (By similarity). | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 23: | Line 21: | ||
==See Also== | ==See Also== | ||
*[[Ion channels|Ion channels]] | *[[Ion channels 3D structures|Ion channels 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Chirgadze | [[Category: Large Structures]] | ||
[[Category: Jackson | [[Category: Chirgadze DY]] | ||
[[Category: Klingauf | [[Category: Jackson AP]] | ||
[[Category: Namadurai | [[Category: Klingauf J]] | ||
[[Category: Rajappa | [[Category: Namadurai S]] | ||
[[Category: Stott | [[Category: Rajappa R]] | ||
[[Category: Weimhofer | [[Category: Stott K]] | ||
[[Category: Weimhofer M]] | |||